<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND AND OBJECTIVES: Tissue plasminogen activator (t-PA) improves the outcome of <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> by recanalization of occluded vessels, but has neurotoxic side effects in experimental <z:hpo ids='HP_0001297'>stroke</z:hpo> models </plain></SENT>
<SENT sid="1" pm="."><plain>Here, the effect of plasminogen activator inhibitor-1 (PAI-1), an endogenous inhibitor of t-PA, on ischemic <z:mpath ids='MPATH_124'>infarct</z:mpath> volume was studied </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: After either permanent ligation or thrombotic occlusion of the middle cerebral artery (<z:chebi fb="70" ids="34342">MCA</z:chebi>), <z:mpath ids='MPATH_124'>infarct</z:mpath> volume, spontaneous reperfusion of thrombosed <z:chebi fb="70" ids="34342">MCA</z:chebi>, t-PA/PAI-1 complex level, and blood-brain barrier (<z:chebi fb="2" ids="33602">BBB</z:chebi>) permeability in the ischemic region was studied in transgenic mice with overexpression of PAI-1 and <z:mp ids='MP_0002169'>wild-type</z:mp> littermate controls and in mice with intracerebroventricular injection of human PAI-1 </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: <z:mpath ids='MPATH_124'>Infarct</z:mpath> volume was smaller in PAI-1 transgenic mice (2.9 +/- 3.7 mm3, mean +/- SD) than in controls (8.9 +/- 5.0 mm3, P &lt; 0.05) after permanent <z:chebi fb="70" ids="34342">MCA</z:chebi> ligation (plasma PAI-1 level 39 +/- 23 ng mL(-1) in transgenic mice vs. 1.5 +/- 0.6 ng mL(-1) in controls), whereas after <z:chebi fb="70" ids="34342">MCA</z:chebi> <z:mp ids='MP_0005048'>thrombosis</z:mp> it was larger in transgenics (13.1 +/- 3.1 mm3) than in controls (8.0 +/- 3.2 mm3, P &lt; 0.05) </plain></SENT>
<SENT sid="4" pm="."><plain>Spontaneous reperfusion of the thrombosed <z:chebi fb="70" ids="34342">MCA</z:chebi> was significantly delayed in transgenic vs. control mice </plain></SENT>
<SENT sid="5" pm="."><plain>In the ligation model, t-PA/PAI-1 complex levels were higher and <z:chebi fb="2" ids="33602">BBB</z:chebi> disruption was more pronounced in the ischemic region </plain></SENT>
<SENT sid="6" pm="."><plain>Human PAI-1 injection reduced <z:mpath ids='MPATH_124'>infarct</z:mpath> volume by about 50% in <z:mp ids='MP_0002169'>wild-type</z:mp> mice but not in t-PA gene deficient mice </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSIONS: High PAI-1 levels reduced <z:mpath ids='MPATH_124'>infarct</z:mpath> volume in the permanent <z:chebi fb="70" ids="34342">MCA</z:chebi> ligation model, but enhanced it in the <z:chebi fb="70" ids="34342">MCA</z:chebi> <z:mp ids='MP_0005048'>thrombosis</z:mp> model </plain></SENT>
</text></document>